Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 14Withdrawn 3Unknown 3Terminated 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Vomiting 2Nausea 2Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Brenner Tumor 1Breast Neoplasms 1

Interventions

Dexamethasone 6fosaprepitant 4Calcium Dobesilate 4Aprepitant 4dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Palonosetron 2Ondansetron 2Granisetron 2Cisplatin 2dolasetron 1casopitant 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Neoadjuvant Therapy 1Methadone 1Lorazepam 1Interviews as Topic 1Immunoenzyme Techniques 1Esomeprazole 1Diphenhydramine 1Cyproheptadine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Vomiting × Granisetron × Clear all
NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

GOG Foundation

Phase NA Terminated
4 enrolled 5 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

NCT01649258 2017-11-17

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

University of Southern California

Phase 1 Terminated
29 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡